Search results for "228"

showing 10 items of 834 documents

COVID-19 y tabaquismo: revisión sistemática y metaanálisis de la evidencia

2021

RESUMEN Objetivo: el objetivo del estudio ha sido responder a las siguientes preguntas: ¿Se asocia el consumo de tabaco en pacientes con Covid-19 con una progresión negativa y desenlace adverso de la enfermedad? y, ¿se asocia el consumo de tabaco, actual y pasado, a una mayor posibilidad de desarrollar COVID-19? Material y Métodos: Se realizó una revisión sistemática (RS) y metaanálisis (MA) de trabajos publicados previamente. La estrategia de búsqueda incluyó todos los descriptores conocidos sobre Covid-19 y tabaco y se realizó en diferentes bases de datos. Se utilizaron modelos estadísticos adecuados para abordar el tamaño del efecto en un metaanálisis: modelo de efectos aleatorios y de e…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industrymedicine.medical_treatmentSmokingOdds ratioPublication biasFixed effects modelRandom effects modelFormer SmokerArticleDisease courseMeta-analysis03 medical and health sciences0302 clinical medicine030228 respiratory systemInternal medicineSystematic reviewmedicineIntubationObservational studyRisk factorCovid-19businessArchivos de Bronconeumología
researchProduct

Les réadmissions après résection pulmonaire en France : la base de données du PMSI

2021

BACKGROUND Readmission within 30 days is an indicator of the quality of care, because it often reflects post-discharge care that is not optimal. The objective of this work is to measure over time on the one hand the readmission rate and on the other hand the number of hospitals with a standardized readmission rate beyond the national average. METHOD All patients with major pulmonary resection for lung cancer in France were extracted from the PMSI national database. Readmission within 30 days was defined as any new hospitalization either in the same hospital or in another establishment. RESULTS From January 1, 2005 to December 31, 2018, 110,603 patients were included. The 30-day all-cause re…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicine.diseaseReadmission rate3. Good health03 medical and health sciencesPneumonectomy0302 clinical medicine030228 respiratory systemEmergency medicinemedicineNational database030212 general & internal medicineNational averageLung resectionPulmonary resectionQuality of careLung cancerbusinessRevue des Maladies Respiratoires
researchProduct

Patient-Ventilator Asynchronies: Clinical Implications and Practical Solutions

2020

Mechanical ventilation is a supportive treatment commonly applied in critically ill patients. Whenever the patient is spontaneously breathing, the pressure applied to the respiratory system depends on the sum of the pressure generated by the respiratory muscles and the pressure generated by the ventilator. Patient-ventilator interaction is of utmost importance in spontaneously breathing patients, and thus the ventilator should be able to adapt to patient's changes in ventilatory demand and respiratory mechanics. Nevertheless, a lack of coordination between patient and ventilator due to a mismatch between neural and ventilator timing throughout the respiratory cycle may make weaning difficul…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyintensive care unitsmedicine.medical_treatmentRespiratory physiologymechanical ventilationCritical Care and Intensive Care Medicineintensive care unit03 medical and health sciencesWork of breathing0302 clinical medicinework of breathingSettore MED/41 - ANESTESIOLOGIAmedicineHumansRespiratory cycleIntensive care medicineasynchrony; diaphragm; dyspnea; intensive care units; mechanical ventilation; work of breathing.Mechanical ventilationVentilators Mechanicalbusiness.industryCritically illRespirationGeneral MedicinedyspneaRespiration ArtificialRespiratory Muscles030228 respiratory systemdiaphragmRespiratory MechanicsBreathingasynchronybusiness
researchProduct

The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD

2020

This exploratory, randomised, double-blind, double-dummy, multicentre, cross-over study explored the effect of 6 weeks of treatment with tiotropium/olodaterol (T/O) versus fluticasone propionate/salmeterol (F/S) on left ventricular filling in patients with chronic obstructive pulmonary disease with functional residual capacity (FRC) >120% predicted and postbronchodilator improvement of FRC ≥7.5%. Overall, 76 patients were randomised across nine sites. Treatment with T/O or F/S increased left ventricular end-diastolic volume index from baseline (adjusted mean change: T/O: 2.317 mL/m2, F/S: 2.855 mL/m2), with no statistically significant difference between treatments. However, T/O resulted…

Pulmonary and Respiratory Medicinemedicine.medical_specialtylcsh:MedicineFluticasone propionatePulmonary Disease Chronic Obstructive03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFunctional residual capacityInternal medicinemedicineHumansMulticenter Studies as TopicPlethysmographIn patient1506030212 general & internal medicineTiotropium BromideLunginhaler devicesRandomized Controlled Trials as Topiclcsh:RC705-779COPDCross-Over Studiesbusiness.industrylcsh:ROlodaterollcsh:Diseases of the respiratory systemrespiratory systemmedicine.diseaseFluticasone-Salmeterol Drug CombinationBenzoxazinesBronchodilator Agentsrespiratory tract diseasesrespiratory measurement030228 respiratory systemchemistryPerspectiveCardiologyCOPD pharmacologySalmeterolVentricular fillingbusinessmedicine.drugBMJ Open Respiratory Research
researchProduct

<p>Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma</p>

2020

Background Anti-IL-5 antibodies represent an established therapy for severe eosinophilic asthma (SEA), but some patients show inadequate response. The objective of this study was to assess the effects of a switch to anti-IL-5Rα therapy in patients with inadequate response to anti-IL-5 therapy. Methods In this retrospective multi-centre, real-life study, we analysed all SEA patients switched from anti-IL-5 to anti-IL-5Rα therapy due to inadequate response or intolerability. Pulmonary function tests, blood gas analyses, asthma control tests (ACT) and oral corticosteroid (OCS) usage were analysed and compared at three timepoints: baseline (BL, before anti-IL-5 therapy), timepoint 1 (T1, under …

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.drug_classGastroenterologyPulmonary function testing03 medical and health scienceschemistry.chemical_compound0302 clinical medicineReslizumabInternal medicineImmunology and AllergyMedicine0601 history and archaeologyAdverse effectInterleukin 5060102 archaeologybiologybusiness.industry06 humanities and the artsBenralizumab030228 respiratory systemchemistrybiology.proteinCorticosteroidAntibodybusinessMepolizumabmedicine.drugJournal of Asthma and Allergy
researchProduct

Withdrawal of inhaled corticosteroids in COPD: A meta-analysis

2017

Background Conflicting findings exist on the benefit of withdrawal of inhaled corticosteroid (ICS) in chronic obstructive pulmonary disease (COPD). We performed a quantitative synthesis in order to assess real impact of ICS discontinuation in COPD patients. Methods We carried out a meta-analysis via random-effects model on the available clinical evidence to evaluate the effect of ICS discontinuation in COPD. Randomized clinical trials and observational real-life studies investigating the effects of ICS withdrawal on the risk of COPD exacerbation, lung function (forced expiratory volume in 1 s [FEV1]) and quality of life (St. George's Respiratory Questionnaire [SGRQ]) were identified by sear…

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.drug_classSocio-culturaleSettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.invention03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineGlucocorticoidQuality of lifeRandomized controlled triallawInhaled corticosteroidForced Expiratory VolumeAdministration InhalationmedicineHumansPharmacology (medical)030212 general & internal medicineIntensive care medicineGlucocorticoidsRandomized Controlled Trials as TopicRespiratory Function TestCOPDInhaled corticosteroidsbusiness.industryChronic obstructive pulmonary diseaseBiochemistry (medical)medicine.diseaseRespiratory Function TestsDiscontinuationrespiratory tract diseasesChronic obstructive pulmonary disease; Inhaled corticosteroids; Withdrawal030228 respiratory systemWithholding TreatmentMeta-analysisRelative riskWithdrawalQuality of LifeCorticosteroidObservational studyChronic obstructive pulmonary disease; Inhaled corticosteroids; Withdrawal; Pulmonary and Respiratory Medicine; Biochemistry (medical); Pharmacology (medical)businessHuman
researchProduct

Development and Validation of the OSA-CPAP Perceived Competence Evaluation Interview

2021

Continuous positive airway pressure (CPAP) is one of the most common therapies for Obstructive Sleep Apnea (OSA). We present a brief, patient-reported outcome measure used to assess patients' levels of adherence with CPAP treatment.A questionnaire was developed based on academic literature. We qualitatively tested a pool of 18 items. It was tested in a sample of 174 patients from the Hospital La Princesa. Next, 1021 patients from Catalonia were evaluated.5 items were removed. Nominal groups referred to three areas: general knowledge about OSA and its risks; CPAP treatment information and expectations; CPAP use, monitoring, and confidence with its use. The 13 retained items maintained the sa…

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.medical_treatmentDisorders of Excessive Somnolence03 medical and health sciences0302 clinical medicineHumansMedicineCpap treatmentGeneral knowledgeContinuous positive airway pressureCompetence (human resources)Sleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryOutcome measuresGeneral Medicinemedicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemQuality of LifePhysical therapyPatient ComplianceFemalebusinessArchivos de Bronconeumología (English Edition)
researchProduct

Uniportal thoracoscopy combined with laparoscopy as minimally invasive treatment of esophageal cancer

2018

A 67-year-old man was referred to our attention for management of esophageal adenocarcinoma, localized at the level of the esophagogastric junction and obstructed the 1/3 of the esophageal lumen. Due to the extension of the disease (T3N1M0-Stage IIIA), the patient underwent neo-adjuvant chemo-radiation therapy and he was then scheduled for a minimally invasive surgical procedure including laparoscopic gastroplasty, uniportal thoracoscopic esophageal dissection and intrathoracic end-to-end esophago-gastric anastomosis. No intraoperative and post-operative complications were seen. The patient was discharged in post-operative day 9. Pathological study confirmed the diagnosis of adenocarcinoma …

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.medical_treatmentEsophageal cancerCase Report030204 cardiovascular system & hematologyAnastomosisVideo-assisted thoracoscopic surgery (VATS)Metastasis03 medical and health sciences0302 clinical medicinemedicineThoracoscopyLaparoscopyUniportalmedicine.diagnostic_testbusiness.industryEsophageal cancermedicine.diseaseSurgeryEsophagectomyDissection030228 respiratory systemEsophagectomyAdenocarcinomaLaparoscopybusiness
researchProduct

Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment

2017

In all fields of medicine, major efforts are currently dedicated to improve the clinical, physiological and therapeutic understanding of disease, and obstructive sleep apnoea (OSA) is no exception. The personalised medicine approach is relevant for OSA, given its complex pathophysiology and variable clinical presentation, the interactions with comorbid conditions and its possible contribution to poor outcomes. Treatment with continuous positive airway pressure (CPAP) is effective, but CPAP is poorly tolerated or not accepted in a considerable proportion of OSA patients. This review summarises the available studies on the physiological phenotypes of upper airway response to obstruction durin…

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.medical_treatmentMEDLINEComorbidityDisease03 medical and health sciences0302 clinical medicinestomatognathic systemPredictive Value of TestsRisk FactorsHumansMedicineContinuous positive airway pressurePrecision MedicineIntensive care medicineLunglcsh:RC705-779Sleep Apnea Obstructivebusiness.industryRespirationSleep apnealcsh:Diseases of the respiratory systemmedicine.diseaseSleep in non-human animalsComorbiditynervous system diseasesrespiratory tract diseases3. Good healthTreatment Outcome030228 respiratory systemPhysical therapyPositional TreatmentSleepbusinessAirway030217 neurology & neurosurgeryEuropean Respiratory Review
researchProduct

The puzzle of metabolic effects of obstructive sleep apnoea in children.

2016

In adults, obstructive sleep apnoea (OSA) is often associated with metabolic alterations. Although obesity is a major culprit [1], large epidemiological studies have reported a metabolic risk associated with OSA that is independent of obesity. In particular, meta-analyses have shown that effective treatment of OSA by continuous positive airway pressure (CPAP) improves glycaemic control in both diabetic [2] and nondiabetic patients [3]. In obese children with obstructive sleep apnoea insulin resistance is common while lipids do not show a clear pattern

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.medical_treatmentPolysomnographySettore MED/10 - Malattie Dell'Apparato RespiratorioCulprit03 medical and health sciences0302 clinical medicineInsulin resistancestomatognathic systemInternal medicineEpidemiologymedicineHumansContinuous positive airway pressureChildTonsillectomySleep Apnea Obstructivebusiness.industryMedicine (all)Metabolic riskmedicine.diseaseSleep in non-human animalsObesitynervous system diseasesrespiratory tract diseasesChild; Humans; Polysomnography; Sleep Apnea Obstructive; Tonsillectomy; Medicine (all); Pulmonary and Respiratory MedicineEndocrinology030228 respiratory systemMetabolic effectsCardiologybusiness030217 neurology & neurosurgeryHumanThe European respiratory journal
researchProduct